Toxicity of ocular medications.
D000328:Adult; D000368:Aged; D000438:Alcohols / Q000009:adverse effects*; D000818:Animals; D001082:Aqueous Humor; D001307:Auditory Perception / Q000187:drug effects; D001769:Blood; D002217:Carbachol / Q000009:adverse effects; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects*; D002386:Cataract / Q000139:chemically induced; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D003315:Cornea / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology; D004837:Epinephrine / Q000009:adverse effects; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000187:drug effects; D008875:Middle Aged; D009995:Osmosis; D010277:Parasympathomimetics / Q000009:adverse effects*; D010539:Permeability; D010830:Physostigmine / Q000009:adverse effects; D010862:Pilocarpine / Q000009:adverse effects; D011680:Pupil / Q000187:drug effects; D011817:Rabbits; D012163:Retinal Detachment / Q000139:chemically induced; D013566:Sympathomimetics / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced
D000438:Alcohols; D002257:Carbonic Anhydrase Inhibitors; D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D013566:Sympathomimetics; D010862:Pilocarpine; D002217:Carbachol; D010830:Physostigmine; D004837:Epinephrine